Toxicology and risk assessment of coumarin: focus on human data.
about
The glycaemic outcomes of Cinnamon, a review of the experimental evidence and clinical trialsThe use of complementary and alternative medicines (CAMs) in the treatment of diabetes mellitus: is continued use safe and effective?Quantification of coumarin in cinnamon and woodruff beverages using DIP-APCI-MS and LC-MS.Efficacy and safety of 'true' cinnamon (Cinnamomum zeylanicum) as a pharmaceutical agent in diabetes: a systematic review and meta-analysis.Acute effect of Ceylon cinnamon extract on postprandial glycemia: alpha-amylase inhibition, starch tolerance test in rats, and randomized crossover clinical trial in healthy volunteers.Extension of Drosophila lifespan by cinnamon through a sex-specific dependence on the insulin receptor substrate chicoMedicinal properties of 'true' cinnamon (Cinnamomum zeylanicum): a systematic review.Authentication of true cinnamon (Cinnamon verum) utilising direct analysis in real time (DART)-QToF-MS.Do cinnamon supplements cause acute hepatitis?The Relation between Hepatotoxicity and the Total Coumarin Intake from Traditional Japanese Medicines Containing Cinnamon Bark.Bioactivity of cinnamon with special emphasis on diabetes mellitus: a review.Cinnamon: Mystic powers of a minute ingredient.Phytotherapy in the Management of Diabetes: A Review.Differentiating parts of Cinnamomum cassia using LC-qTOF-MS in conjunction with principal component analysis.Assessment of coumarin levels in ground cinnamon available in the Czech retail market.[Biomarkers of internal exposure to toxicologically relevant contaminants in food].An Improved LC-MS/MS Method for Simultaneous Determination of the Eleven Bioactive Constituents for Quality Control of Radix Angelicae Pubescentis and Its Related Preparations.Bioprofiling of Cosmetics with Focus on Streamlined Coumarin Analysis.Aroma, Sugar and Anthocyanin Profile of Fruit and Seed of Mahlab (Prunus mahaleb L.): Optimization of Bioactive Compounds Extraction by Simplex Lattice Mixture Design
P2860
Q26782181-99C01562-4D68-41B4-BDD1-C3D704E25BE5Q27011434-B14A8FEF-63BE-40D9-815F-69DB8F0C773CQ33458811-6B1FA482-B1CF-45B9-9DBA-91A4841B189CQ34294044-B9CBB47C-84A7-42DE-8735-369397314FDFQ34581718-79B2C0D0-1464-4476-89B8-CA2CA2F30EA3Q35022902-4B6C1B80-B725-4E9C-999F-D68607085E4DQ35024132-54019899-D303-48CA-9C8C-A01D2E5F6530Q35447091-E229F7C4-7712-4736-AC09-1868D3D4CCE1Q35579259-2753E54F-0C6F-4477-9606-93927B5180EEQ37018879-78E540B9-F7F2-49BB-B519-04CA0C7BE149Q37946916-68355B5C-41E4-4F61-8439-8B7758FDED19Q38537509-ADA641F8-475A-4595-BD3C-C7D9FB34D2EEQ47210608-D9229895-6127-46DC-BF92-B037BAE87F36Q47335207-67452BC5-7C86-4BF4-AABD-55BA6BB9D153Q51557661-DF17F799-7425-4924-A5AF-733ED39FCC63Q52838987-EAA602ED-BB3B-42F9-914C-9A7F543C631BQ55456189-2D58FB52-F64A-46DA-86B2-8821B92EC4FFQ55686956-26D7A709-2346-45F1-8FE8-4F0D65EA348AQ57902736-C69E0CEB-0489-4D7A-807C-45626CC13D10
P2860
Toxicology and risk assessment of coumarin: focus on human data.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Toxicology and risk assessment of coumarin: focus on human data.
@ast
Toxicology and risk assessment of coumarin: focus on human data.
@en
Toxicology and risk assessment of coumarin: focus on human data.
@nl
type
label
Toxicology and risk assessment of coumarin: focus on human data.
@ast
Toxicology and risk assessment of coumarin: focus on human data.
@en
Toxicology and risk assessment of coumarin: focus on human data.
@nl
prefLabel
Toxicology and risk assessment of coumarin: focus on human data.
@ast
Toxicology and risk assessment of coumarin: focus on human data.
@en
Toxicology and risk assessment of coumarin: focus on human data.
@nl
P2093
P2860
P356
P1476
Toxicology and risk assessment of coumarin: focus on human data.
@en
P2093
Friederike Wöhrlin
Gerhard Heinemeyer
Klaus Abraham
Oliver Lindtner
P2860
P304
P356
10.1002/MNFR.200900281
P577
2010-02-01T00:00:00Z